Clinical trial
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around…
NCT00316225 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00316225 |
|---|---|
| Title | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen |
| Official title | A Phase 2 Study of ALIMTA in Solid Tumor Patients With Stable Third-Space Fluid |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer, Mesothelioma, Lung Neoplasms |
| Intervention type | Drug |
| Interventions | pemetrexed |
| Enrollment | 31 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 20, 2006 |
| Last update posted | Jul 9, 2010 |
| Countries | Denmark, Germany, Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: